2011 Q1/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Cilag AG
8.3
2 +31 Actelion Ltd.
8.2
3 +0 Lumavita AG
8.1
4 -2 Newron
8.0
5 -1 Medinova AG
7.8
6 +0 Nycomed Pharma AG
7.8
7 -2 Axentis Pharma AG
7.7
8 -7 Neurimmune Therapeutics AG
7.3
9 +33 Antares Pharma AG
7.1
10 -3 ArisGen SA
7.0
11 +0 Takeda Pharma AG
6.8
12 +0 Pharmakon Ltd.
6.8
13 +1 Arpida AG
6.8
14 +25 Med Discovery S.A.
6.8
15 +9 Neurotune
6.7
16 +0 Pentapharm (DSM Nutritional Products AG)
6.7
17 -8 BioPartners GmbH
6.7
18 -8 4-Antibody AG
6.7
19 +0 Dr. Wild & Co. AG
6.6
20 -9 OMIDA AG
6.6
21 -4 AmVac AG
6.5
22 +0 Evolva SA
6.4
23 +13 Johnson & Johnson Pharmaceutical Research & Development
6.3
24 -8 Tricom GmbH, Pharma Division
6.3
25 +0 GlaxoSmithKline AG
6.3
26 -18 Siegfried AG
6.3
27 +1 Auris Medical AG
6.2
28 -10 Max Zeller Söhne AG
6.2
29 -8 Molecular Partners
6.2
30 -5 Kuros Biosurgery AG
6.1
31 +0 Virbac Schweiz AG
6.1
32 -9 Cytos Biotechnology AG
6.0
33 +0 Teva Pharma AG
6.0
34 -15 GKL Biotec AG
5.9
35 -9 Octapharma AG
5.9
36 -9 Lipideon Biotechnology AG
5.9
37 -24 Biogen Idec International GmbH
5.9
38 -8 Vifor (International) Ltd.
5.7
39 -7 Helvepharm AG
5.7
40 +5 Novartis International AG
5.7
41 -10 Galenica Ltd.
5.7
42 +13 Permamed AG
5.7
43 +31 AstraZeneca AG
5.6
44 +0 A. Menarini AG
5.6
45 +0 Sanofi-Aventis
5.6
46 +0 Merz Pharma (Schweiz) AG
5.6
47 -6 Anavex Life Sciences Corp.
5.5
48 -36 Axenoll AG
5.5
49 +0 Bristol-Myers Squibb SA
5.5
50 -21 BioVersys GmbH
5.5


Changes in rank are compared to 2010 Q4/Global Life Sciences. Since then, 31 sites entered the survey and 12 sites could not be included in the rankings (4 more since last time). Build your own. Report statistics.